Osborn Williams & Donohoe LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% during the second quarter, Holdings Channel reports. The fund owned 13,196 shares of the healthcare conglomerate’s stock after buying an additional 400 shares during the period. Osborn Williams & Donohoe LLC’s holdings in UnitedHealth Group were worth $2,447,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in UNH. Gulf International Bank UK Ltd boosted its stake in shares of UnitedHealth Group by 2.9% in the first quarter. Gulf International Bank UK Ltd now owns 300,307 shares of the healthcare conglomerate’s stock valued at $49,253,000 after buying an additional 8,593 shares during the last quarter. Raymond James Trust N.A. boosted its stake in shares of UnitedHealth Group by 0.8% in the first quarter. Raymond James Trust N.A. now owns 55,809 shares of the healthcare conglomerate’s stock valued at $9,153,000 after buying an additional 456 shares during the last quarter. Paradigm Financial Advisors LLC boosted its stake in shares of UnitedHealth Group by 0.4% in the first quarter. Paradigm Financial Advisors LLC now owns 2,761 shares of the healthcare conglomerate’s stock valued at $452,000 after buying an additional 11 shares during the last quarter. Hefty Wealth Partners purchased a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $961,000. Finally, Trust Co boosted its stake in shares of UnitedHealth Group by 0.4% in the fourth quarter. Trust Co now owns 5,056 shares of the healthcare conglomerate’s stock valued at $809,000 after buying an additional 20 shares during the last quarter. 86.37% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Incorporated (NYSE UNH) traded up 0.26% during trading on Friday, hitting $193.07. 1,230,805 shares of the stock traded hands. The company’s 50 day moving average is $189.18 and its 200 day moving average is $174.51. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $196.04. The company has a market capitalization of $186.67 billion, a P/E ratio of 23.19 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same quarter in the prior year, the firm earned $1.96 earnings per share. The firm’s revenue was up 7.7% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The legal version of this story can be viewed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-stake-increased-by-osborn-williams-donohoe-llc/1475176.html.

Several equities research analysts recently commented on the company. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 target price on the stock in a report on Tuesday, August 1st. Sanford C. Bernstein reissued an “outperform” rating and set a $210.00 target price (up previously from $190.00) on shares of UnitedHealth Group in a report on Saturday, July 22nd. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Cantor Fitzgerald reissued an “overweight” rating and set a $208.00 target price on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $212.00 target price on shares of UnitedHealth Group in a report on Thursday, July 20th. One analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $200.24.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold 15,540 shares of company stock valued at $2,873,320 in the last three months. 0.89% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.